$42.88
0.37% yesterday
Nasdaq, Jun 02, 10:00 pm CET
ISIN
US30161Q1040
Symbol
EXEL

Exelixis, Inc. Target price 2025 - Analyst rating & recommendation

Exelixis, Inc. Classifications & Recommendation:

Buy
55%
Hold
45%

Exelixis, Inc. Price Target

Target Price $40.89
Price $42.88
Deviation
Number of Estimates 19
19 Analysts have issued a price target Exelixis, Inc. 2026 . The average Exelixis, Inc. target price is $40.89. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 11 Analysts recommend Exelixis, Inc. to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Exelixis, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Exelixis, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jan '25 2026
Estimates
Revenue Billion $ 2.17 2.59
19.38%
EBITDA Margin 33.14% 39.40%
18.88%
Net Margin 24.04% 27.48%
14.33%

18 Analysts have issued a sales forecast Exelixis, Inc. 2026 . The average Exelixis, Inc. sales estimate is

$2.6b
Unlock
. This is
12.62% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.1b 32.71%
Unlock
, the lowest is
$2.1b 7.35%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.2b
2026
$2.6b 19.38%
Unlock
2027
$3.0b 14.87%
Unlock
2028
$3.3b 10.87%
Unlock
2029
$3.7b 12.15%
Unlock

4 Analysts have issued an Exelixis, Inc. EBITDA forecast 2026. The average Exelixis, Inc. EBITDA estimate is

$1.0b
Unlock
. This is
20.83% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.1b 28.17%
Unlock
, the lowest is
$841m 0.36%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $719m
2026
$1.0b 41.93%
Unlock
2027
$1.4b 33.61%
Unlock

EBITDA Margin

2025 33.14%
2026
39.40% 18.88%
Unlock
2027
45.83% 16.32%
Unlock

15 Exelixis, Inc. Analysts have issued a net profit forecast 2026. The average Exelixis, Inc. net profit estimate is

$711m
Unlock
. This is
10.55% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.0b 61.11%
Unlock
, the lowest is
$388m 39.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $521m
2026
$711m 36.49%
Unlock
2027
$896m 25.99%
Unlock
2028
$1.1b 23.44%
Unlock
2029
$1.4b 29.37%
Unlock

Net Margin

2025 24.04%
2026
27.48% 14.33%
Unlock
2027
30.14% 9.68%
Unlock
2028
33.56% 11.35%
Unlock
2029
38.71% 15.35%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jan '25 2026
Estimates
Earnings Per Share $ 1.76 2.59
47.16%
P/E 16.58
EV/Sales 4.12

15 Analysts have issued a Exelixis, Inc. forecast for earnings per share. The average Exelixis, Inc. EPS is

$2.59
Unlock
. This is
16.14% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$3.77 69.06%
Unlock
, the lowest is
$1.41 36.77%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.76
2026
$2.59 47.16%
Unlock
2027
$3.26 25.87%
Unlock
2028
$4.02 23.31%
Unlock
2029
$5.21 29.60%
Unlock

P/E ratio

Current 19.23 40.60%
2026
16.58 13.77%
Unlock
2027
13.16 20.63%
Unlock
2028
10.66 19.00%
Unlock
2029
8.24 22.70%
Unlock

Based on analysts' sales estimates for 2026, the Exelixis, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.64 60.00%
2026
4.12 11.24%
Unlock
2027
3.59 12.95%
Unlock
2028
3.23 9.81%
Unlock
2029
2.88 10.84%
Unlock

P/S ratio

Current 5.09 48.67%
2026
4.52 11.20%
Unlock
2027
3.93 12.95%
Unlock
2028
3.55 9.81%
Unlock
2029
3.16 10.83%
Unlock

Current Exelixis, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup
Locked
Locked
Locked May 15 2025
Stifel
Locked
Locked
Locked May 14 2025
Morgan Stanley
Locked
Locked
Locked May 14 2025
RBC Capital
Locked
Locked
Locked May 14 2025
JMP Securities
Locked
Locked
Locked Apr 17 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 27 2025
RBC Capital
Locked
Locked
Locked Mar 13 2025
Analyst Rating Date
Locked
Citigroup:
Locked
Locked
May 15 2025
Locked
Stifel:
Locked
Locked
May 14 2025
Locked
Morgan Stanley:
Locked
Locked
May 14 2025
Locked
RBC Capital:
Locked
Locked
May 14 2025
Locked
JMP Securities:
Locked
Locked
Apr 17 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 27 2025
Locked
RBC Capital:
Locked
Locked
Mar 13 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today